P2.03-31 Chemokine Receptor CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
Year: 2019
Type: article
Source: Journal of Thoracic Oncology
Authors: J. Becker, Y. Gao, M. Soucheray, I. Pulido, E. Kikuchi, M. Rodríguez, R. Gandhi, A. Lafuente-Sánchis, M. Aupi, J. Alcacer Fernandez-Coronado, P. Martín, A. Cremades, J. Galbis-Caravajal, J. Alcacer, C. Christensen, P. Simms, A. Hess, H. Asahina, M. Kahle, F. Al-Shahrour, J. Borgia, A. Lahoz, A. Insa, O. Juan, P. Jänne, K. Wong, J. Carretero, T. Shimamura
Institutions: University of Illinois Chicago, Loyola University Chicago, Universitat de València, Hokkaido University Hospital, Hospital de La Ribera, IDCQ Hospitales y Sanidad, S.L.U., Hospital Clínico Universitario de Valencia, Dana-Farber Cancer Institute, Spanish National Cancer Research Centre, Rush University Medical Center, Instituto de Investigación Sanitaria La Fe, Dana-Farber/Harvard Cancer Center, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2981691946
